Personalized Medicine Gains Traction
Since completion of the Human Genome Project in 2003, the promise of personalized medicine (PM) caused many to consider its effect on bio-science, pharma and healthcare delivery. Physicians contemplate a future in which patients enter their office equipped with symptoms and a list of the genetic variants they posses and questions about what they mean.
The problem hasn’t materialized because the cost of discovering and developing drugs customized to the needs of a sub-genetic group have been prohibitive. Today however, IT frameworks like Hadoop deploy massively powerful, inexpensive processing power. Now the huge genomic database becomes a more accessible resource to develop medications that are effective for targeted patient populations.
These new drugs offer improved cost-effectiveness over blockbuster drugs for conditions like high cholesterol or hypertension. Physicians will spend less time and money in trial and error to find which drugs work for which patients.
Disruption in Healthcare
In my last post, I raised the question, “Will Personalized Medicine have a disruptive influence on medical practice?” Those familiar with Christensen’s theory of disruptive innovation understand that market leaders focus resources on product development for advanced users who don’t care about cost. Often products contain features and benefits that don’t matter to most users. This leaves room for competitors to develop new technologies and business models to meet the needs of average consumers and “disrupt” the market leader’s business from the bottom up.
Healthcare is not like other businesses. The role of payers and policymakers as well as the interests of public health intervene and create barriers to natural market forces. These factors slow the rate of disruption. Yet there will be fundamental change in the way physicians and patients interact as PM gains traction.
Four ways PM will disrupt healthcare delivery
#1 Predictive, not reactive:
- Rather than waiting to treat symptoms of a disease that occur, physicians can predict which diseases a patient is susceptible to.
- The physician develops a personalized health plan to prevent or detect these diseases early.
- Patients will become a true partner in the delivery of healthcare, monitoring their progress and reporting results to their caregivers.
- Home testing may replace testing in the doctor’s office.
- Fewer office visits, less face time with the PCP is less expensive, but is it better medicine?
#2 More information on more treatment options:
- Physicians prepare to answer patients’ questions about new genetic tests and the treatments for their sub-group.
- Continuous access to up to date, peer-reviewed medical information will increase dramatically.
- As more options for care become available, will the patient’s trust in the sources of clinical information and outcomes begin to erode?
#3 New ethical and moral obligations:
- What is the physician’s role with patients on the moral and ethical questions surrounding access to genetic tests?
- If one family member wants genetic testing and another doesn’t and a serious disease potential becomes known, what is the physician’s obligation to inform?
#4 Physician’s role in decision to test:
- Should patients have their own testing done without supervision of a physician?
- Should tests be offered for genetic disorders for which no treatment is available?
- Who pays for development of testing and treatment for small sub-groups of patients?
What do you think? Will PM disrupt or enhance healthcare delivery?
- Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure (eurekalert.org)
- DIYgenomics community computing health models (slideshare.net)
- Ex-Cleveland Clinic colleagues Topol, Nissen at odds on personalized medicine (medcitynews.com)
- Four Themes to Watch in Personalized Medicine (xconomy.com)
- Working with Healthcare Stakeholders towards Brain-Based Personalized Medicine (sharpbrains.com)
- The State of Personalized Medicine: The Role of Biomarkers (sharpbrains.com)